🇺🇸 FDA
Patent

US 8513198

Pharmaceutical formulation for reducing pain

granted A61KA61K31/137A61K31/195

Quick answer

US patent 8513198 (Pharmaceutical formulation for reducing pain) held by Jazz Pharmaceuticals International III Limited expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals International III Limited
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/137, A61K31/195, A61K31/4168, A61K31/445